Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00690352 · ClinicalTrials.gov registry record

Specialized Substance Abuse Supervision (SSAS) Versus Non-SSAS Recidivism Rates Among Nebraska Felony Drug Offenders

A clinical trial, sponsored by University of Nebraska.

Completed
Registry status
344
Enrollment target

NCT00690352: Completed study, sponsored by University of Nebraska.

NCT00690352 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 344 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00690352 has completed, sponsored by University of Nebraska.

COMPLETED
Registry status
344 participants
Enrollment target

Study Summary

This social science study hypothesizes that convicted felony drug offenders in Nebraska who participated in Specialized Substance Abuse Supervision (SSAS) as part of their probation or parole showed significantly better outcomes (specifically, less recidivism) at six months post-entrance to SSAS compared to those who did not participate in SSAS.

Primary Outcome

Proportion of individuals who re-offend during the six months following sentencing

Interventions

  • BEHAVIORAL Specialized Substance Abuse Supervision (SSAS)

Trial Details

FieldValue
Enrollment Target 344 participants
Start Date 2008-03-05
Est. Completion 2008-08-20
University of Nebraska

407 total trials

What the finished NCT00690352 record still lists

NCT00690352 is an observational study that tracks outcomes without assigning an intervention. The registered 344 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Specialized Substance Abuse Supervision (SSAS) is the first listed.

NCT00690352 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00690352 about?

NCT00690352 is a clinical study titled "Specialized Substance Abuse Supervision (SSAS) Versus Non-SSAS Recidivism Rates Among Nebraska Felony Drug Offenders". This social science study hypothesizes that convicted felony drug offenders in Nebraska who participated in Specialized Substance Abuse Supervision (SSAS) as part of their probation or parole showed significantly better outcomes (specifically, less recidivism) at six months post-entrance to SSAS com...

What is the current status of trial NCT00690352?

This trial is currently completed. The enrollment target is 344 participants. The study started on 2008-03-05. Estimated completion is 2008-08-20.

What interventions are being tested in trial NCT00690352?

The interventions under investigation include: Specialized Substance Abuse Supervision (SSAS) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00690352?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06733363 · 344 participants · Phase 2

    A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer

  • NCT07179380 · 344 participants · Phase 3

    Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • NCT07304024 · 344 participants · Phase 1

    A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound

  • NCT03972657 · 345 participants · Phase 1

    A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00690352, the US trial registry maintained by the National Library of Medicine. NCT00690352 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.